Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea L Schaffer

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
The Medical Journal of Australia|February 19, 2020
Antiplatelet therapy within 30 days of percutaneous coronary intervention with stent implantationBenjumin Hsu, Michael O Falster, Andrea L Schaffer, et al.
Drug and Alcohol Review|May 12, 2020
Potentially inappropriate benzodiazepine use in Australian adults: A population-based study (2014-2017)Danni Zheng, Jonathan Brett, Benjamin Daniels, et al.
The Australian and New Zealand Journal of Psychiatry|May 16, 2019
Trajectories of antipsychotic use before and during pregnancy and associated maternal and birth characteristicsAndrea L Schaffer, Helga Zoega, Duong T Tran, et al.
The Medical Journal of Australia|March 24, 2025
The relative toxicity of medicines detected after poisoning suicide deaths in Australia, 2013-19: a data linkage case series studyJessy Lim, Nicholas A Buckley, Kate Chitty, et al.
JAMA Psychiatry|July 26, 2023
Substances Detected During Coroner Postmortem Toxicology Analyses in Poisoning- and Nonpoisoning-Related SuicidesJessy S Lim, Nicholas A Buckley, Rose Cairns, et al.
The Medical Journal of Australia|March 23, 2020
Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicineAndrea L Schaffer, Rose Cairns, Jared A Brown, et al.
British Journal of Clinical Pharmacology|November 26, 2022
Potential drug-drug interactions due to concomitant medicine use among people living with HIV on antiretroviral therapy in AustraliaJuliana de Oliveira Costa, Stella Lau, Nicholas Medland, et al.
Pharmacoepidemiology and Drug Safety|October 13, 2020
Patterns of opioid use in older people diagnosed with cancer in New South Wales, AustraliaHanna E Tervonen, Andrea L Schaffer, Tim Luckett, et al.
The Australian and New Zealand Journal of Psychiatry|August 16, 2025
New use of antidepressants among Australians up to 24 years of age remains high after the COVID-19 pandemic emergency eraJuliana de Oliveira Costa, Malcolm B Gillies, Andrea L Schaffer, et al.
Internal Medicine Journal|February 1, 2024
Quality use of publicly subsidised tapentadol in Australia: a population-based analysisXimena Camacho, Andrea L Schaffer, Jonathan Brett, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
The Medical Journal of Australia|February 19, 2020
Antiplatelet therapy within 30 days of percutaneous coronary intervention with stent implantationBenjumin Hsu, Michael O Falster, Andrea L Schaffer, et al.
Drug and Alcohol Review|May 12, 2020
Potentially inappropriate benzodiazepine use in Australian adults: A population-based study (2014-2017)Danni Zheng, Jonathan Brett, Benjamin Daniels, et al.
The Australian and New Zealand Journal of Psychiatry|May 16, 2019
Trajectories of antipsychotic use before and during pregnancy and associated maternal and birth characteristicsAndrea L Schaffer, Helga Zoega, Duong T Tran, et al.
The Medical Journal of Australia|March 24, 2025
The relative toxicity of medicines detected after poisoning suicide deaths in Australia, 2013-19: a data linkage case series studyJessy Lim, Nicholas A Buckley, Kate Chitty, et al.
JAMA Psychiatry|July 26, 2023
Substances Detected During Coroner Postmortem Toxicology Analyses in Poisoning- and Nonpoisoning-Related SuicidesJessy S Lim, Nicholas A Buckley, Rose Cairns, et al.
The Medical Journal of Australia|March 23, 2020
Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicineAndrea L Schaffer, Rose Cairns, Jared A Brown, et al.
British Journal of Clinical Pharmacology|November 26, 2022
Potential drug-drug interactions due to concomitant medicine use among people living with HIV on antiretroviral therapy in AustraliaJuliana de Oliveira Costa, Stella Lau, Nicholas Medland, et al.
Pharmacoepidemiology and Drug Safety|October 13, 2020
Patterns of opioid use in older people diagnosed with cancer in New South Wales, AustraliaHanna E Tervonen, Andrea L Schaffer, Tim Luckett, et al.
The Australian and New Zealand Journal of Psychiatry|August 16, 2025
New use of antidepressants among Australians up to 24 years of age remains high after the COVID-19 pandemic emergency eraJuliana de Oliveira Costa, Malcolm B Gillies, Andrea L Schaffer, et al.
Internal Medicine Journal|February 1, 2024
Quality use of publicly subsidised tapentadol in Australia: a population-based analysisXimena Camacho, Andrea L Schaffer, Jonathan Brett, et al.
Pageof 8